These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22653545)

  • 21. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion.
    Ozdek SC; Aydin B; Gürelik G; Bahçeci U; Hasanreisoğlu B
    Int Ophthalmol; 2005; 26(1-2):27-34. PubMed ID: 16783483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
    Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Chen SD; Sundaram V; Lochhead J; Patel CK
    Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan.
    Cheng KC; Wu WC; Lin CJ
    Eye (Lond); 2009 Apr; 23(4):849-57. PubMed ID: 18535613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
    Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P
    Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous intravitreal injection of triamcinolone acetonide and tissue plasminogen activator for central retinal vein occlusion: a pilot study.
    Yamamoto T; Kamei M; Sayanagi K; Matsumura N; Nishida K; Sakaguchi H; Tsujikawa M; Tano Y
    Br J Ophthalmol; 2011 Jan; 95(1):69-73. PubMed ID: 20494908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion.
    Yamaike N; Kita M; Tsujikawa A; Miyamoto K; Yoshimura N
    Am J Ophthalmol; 2007 Feb; 143(2):342-4. PubMed ID: 17258527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
    Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN
    Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.
    Noma H; Funatsu H; Mimura T; Harino S; Shimada K
    Retina; 2011 Nov; 31(10):2102-8. PubMed ID: 21734622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
    Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
    Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Shimada K
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):231-6. PubMed ID: 22304619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.
    Shimura M; Yasuda K; Nakazawa T; Hirano Y; Sakamoto T; Ogura Y; Shiono T
    Retina; 2011 Apr; 31(4):748-54. PubMed ID: 21836404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R
    Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
    Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
    Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion.
    Mylonas G; Sacu S; Dunavoelgyi R; Matt G; Blum R; Buehl W; Pruente C; Schmidt-Erfurth U;
    Retina; 2013 Jun; 33(6):1220-6. PubMed ID: 23584689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.